For media enquiries please contact one of the following people:
Pharmaceuticals and Consumer Health: Fiona Tigar
Phone: +61 2 9391 6009
Crop Science and Animal Health: Lachlan Bird
Phone: +61 3 9248 6851
Bayer New Zealand: William Malpass
Phone: +64 9 441 8591
Bayer to acquire consumer care business of US-based Merck & Co., Inc. and to engage in strategic pharma cooperation in the field of sGC modulators
Purchase price of USD 14.2 billion in cash for Merck & Co., Inc.’s consumer care business / Bayer to become the OTC leader in North America and Latin America and achieve top global positions in key OTC product categories / Strategic pharma collaboration with Merck & Co., Inc. in the field of sGC modulators for which Bayer will receive a USD 1 billion upfront payment, plus substantial additional sales milestones More
Tougher control for beet crop weeds on the way
New Zealand farmers will have a powerful new addition to their weed control arsenal this spring.
Bayer CropScience New Zealand has just been given registration for its new four-way herbicide, Betanal Quattro, which for the first time brings together all four of the main active ingredients in one single product for the control of broad-leaved weeds and annual grasses in fodder beet crops.
Bayer: Very successful start to 2014
Encouraging business development in all subgroups / Strong growth for recently launched pharmaceutical products / Group sales EUR 10,555 million (plus 2.8 percent, Fx & portfolio adj. plus 8.4 percent) / EBIT moves ahead by 18.4 percent to EUR 2,096 million / EBITDA before special items rises by 11.6 percent to EUR 2,738 million – despite negative currency effects of 8 percent / Net income advances by 22.7 percent to EUR 1,423 million / Core earnings per share increase by 14.7 percent to EUR 1.95 / Forecast for 2014 confirmed More
Bayer continues successful course in anniversary year
Dynamic development in the Life Science businesses, MaterialScience below expectations / Outstanding growth for recently launched pharmaceutical products – estimate of combined peak annual sales potential for the five products increased to at least EUR 7.5 billion / Group sales EUR 40,157 million (plus 1.0 percent; Fx & portfolio adj.: plus 5.1 percent) / EBIT advanced by 25.6 percent to EUR 4,934 million / EBITDA before special items up by 1.5 percent to EUR 8,401 million / Net income increased 32.7 percent to EUR 3,189 million / Core earnings per share up 5.8 percent to EUR 5.61 / Forecast for 2014: further growth in sales and earnings More
Bayer proposes increased dividend for 2013 of EUR 2.10 per share
Leverkusen, February 26, 2014 – At its meeting today, the Supervisory Board of Bayer AG accepted the proposal of the Board of Management to recommend to the Annual Stockholders’ Meeting on April 29, 2014 that a dividend of EUR 2.10 per share be paid for 2013 (2012: EUR 1.90). More
Breeding a better future for Aussie agriculture
Bayer CropScience today opened its Wheat & Oilseeds Breeding Centre near Horsham, Victoria confirming an essential partnership between science and agriculture for the future success of our farmers.
The state-of-the-art breeding centre is the first of its kind in this country and will focus on developing wheat and oilseeds varieties with higher yields and productivity improvements specifically for Australian agriculture.
Innovations for more quality of life
Key issues in medicine, agriculture and materials: companion diagnostics in cancer therapy, biological crop protection and efficient wind power generation / Research as a digital experience: research app with videos, image galleries, 3D animations and infographics / Attractive service for educators: learning materials for the iPad and new infographic database More
|Previous||1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29||Next|